ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

STLN // Starling Oncology Inc.

ANR <GO> NASDAQ RQD COCKPIT → CIK 0001799191 ↗
Health Care • Medical/Nursing Services
$6.65 ▲ +0.01 (+0.15%)
MKT CAP: $677.7M • VOL: 1.11M
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8 SELL: 2
12M STREET TARGET RANGE IMPLIED: +14.0%
LOW
$6
MEDIAN
$7
MEAN
$8
HIGH
$9
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100 EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE STLN TAPE
STLN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>) CURRENT 90D STREET CONSENSUS
INSTITUTION / ANALYST ACTION RATING TARGET PRIOR PT CALL DATE PX AT CALL RET SINCE CALL 1Y ACCURACY BS GRADE
Morgan Stanley Institutional
Equity Desk
REITERATE OUTPERFORM $8.05 $7.65 2025-02-14 $6.05 +9.9% 78% A
Goldman Sachs Global Research
Sector Coverage
TARGET REV STRONG BUY $8.38 $7.85 2025-02-06 $6.25 +6.4% 74% A
J.P. Morgan Securities
US Large Cap
REITERATE BUY $7.58 $7.32 2025-01-29 $6.38 +4.2% 67% B
Bernstein Autonomous
Forensic Coverage
INITIATE HOLD $6.78 — 2025-01-17 $6.52 +2.0% 61% B
Barclays Capital
Americas Research
DOWNGRADE UNDERPERFORM $5.85 $6.32 2025-01-09 $5.92 -11.2% 42% D
UBS Investment Bank
Institutional Desk
UPGRADE BUY $7.91 $6.92 2024-12-18 $5.79 +14.9% 72% A
Citigroup Global Markets
Sector Lead
TARGET REV HOLD $6.45 $6.72 2024-12-04 $6.18 -4.3% 48% C